Sesen Bio
www.sesenbio.comWe are passionate in our commitment to save and improve the lives of patients. Sesen Bio is a late-stage company developing fusion protein medicines for the treatment of patients with cancer. In February 2021, the FDA accepted for filing the Company’s BLA for Vicineum™, a potential best-in-class treatment for non-muscle invasive bladder cancer.
Read more
We are passionate in our commitment to save and improve the lives of patients. Sesen Bio is a late-stage company developing fusion protein medicines for the treatment of patients with cancer. In February 2021, the FDA accepted for filing the Company’s BLA for Vicineum™, a potential best-in-class treatment for non-muscle invasive bladder cancer.
Read more
Country
State
Massachusetts
City (Headquarters)
Newton
Industry
Employees
11-50
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President , Corporate Strategy and Investor Relations
Email ****** @****.comPhone (***) ****-****Vice President , Supply Chain and Manufacturing Strategy
Email ****** @****.comPhone (***) ****-****Chief Technology Officer
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****
Technologies
(25)
